Nectar Lifesciences Limited (NECLIFE)

33.22

INR
-0.98(-2.87%)
As of December 6, 2024 9:44:00 AM

Nectar Lifesciences Limited Share Price Information

24 hour Low and High

Low: 33.9
High: 34.25

All time High

53.92

Price Change 1h

+₹-0.93 +-2.72%

Price Change 1d

+₹-0.93 +-2.72%

Price Change 1w

+₹-2.04 +-5.79%

Nectar Lifesciences Limited Market Information

Exchange

NSE

Market Cap

808.83 Cr

About Nectar Lifesciences Limited Share

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1686

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive
  • Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
  • Nectar Lifescience's Stock Price Soars, Outperforms Sector and Market in Recent Performance
  • Nectar Lifescience Downgraded to 'Sell' by MarketsMOJO: What Investors Need to Know
  • Is Nectar Lifesciences Limited's (NSE:NECLIFE) P/E Ratio Really That Good?

FAQs

Nectar Lifesciences Limited (NECLIFE)

33.22

INR
-0.98(-2.87%)
As of December 6, 2024 9:44:00 AM

Nectar Lifesciences Limited Share Price Information

24 hour Low and High

Low: 33.9
High: 34.25

All time High

53.92

Price Change 1h

+₹-0.93 +-2.72%

Price Change 1d

+₹-0.93 +-2.72%

Price Change 1w

+₹-2.04 +-5.79%

Nectar Lifesciences Limited Market Information

Exchange

NSE

Market Cap

808.83 Cr

About Nectar Lifesciences Limited Share

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1686

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive
  • Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
  • Nectar Lifescience's Stock Price Soars, Outperforms Sector and Market in Recent Performance
  • Nectar Lifescience Downgraded to 'Sell' by MarketsMOJO: What Investors Need to Know
  • Is Nectar Lifesciences Limited's (NSE:NECLIFE) P/E Ratio Really That Good?

FAQs